AI synthesis of three filings for Teradyne, Inc.
Sources: the Annual Report on Form 10-K for fiscal year 2025 (year ended December 31, 2025), accession 0001193125-26-059002; the Quarterly Report on Form 10-Q for the quarter ended September 27, 2026, accession 0001193125-26-441091; and the third-quarter 2026 earnings release furnished as Exhibit 99.1 to the Form 8-K filed October 28, 2026, accession 0001193125-26-434981.
Business
From the FY2025 10-K, accession 0001193125-26-059002, unless noted.
Teradyne sells automated test equipment and industrial robots. Its test systems are bought by chipmakers and their manufacturing partners to test semiconductors, wireless products, data-storage devices, silicon photonics and complex electronics before they ship; its robots, collaborative robot arms and autonomous mobile robots, are sold to manufacturing, logistics and industrial customers. Revenue comes overwhelmingly from test equipment and related service: in 2025 Semiconductor Test produced 79% of the $3,190.0 million in revenue, Product Test 11% and Robotics 10%. About 83% of 2025 revenue was products and 17% service. Sales are global and Asia-weighted, 89% of 2025 revenue came from customers outside the United States, led by Taiwan (36%), China (14%) and Korea (14%), measured by customer site.
The company reports three segments:
- Semiconductor Test, wafer-level, package and system-level test systems for semiconductors, plus hard-disk-drive and solid-state-drive testers. Platforms include the FLEX Test Platform (the UltraFLEXplus tester is aimed at complex compute devices, with data centers and AI now its main drivers), the J750 and IP750 for high-volume microcontrollers and image sensors, Magnum for flash, DRAM and high-bandwidth memory (HBM), and ETS/Eagle for analog, mixed-signal and power devices including silicon carbide and gallium nitride. The Integrated System Test group houses system-level testers and storage testers. Customers are integrated device manufacturers, fabless designers, foundries and outsourced assembly-and-test providers (OSATs).
- Product Test, created as a segment in March 2025 by combining production board test, defense and aerospace, and wireless test. It sells test systems, instruments and services for electronic and photonic assemblies and modules to data-center, automotive/industrial, defense/aerospace and consumer-electronics customers. It includes Quantifi Photonics (photonic integrated circuit test), acquired May 31, 2025 for $127.2 million, and, since April 2026, the MultiLane Test Products joint venture (high-speed interconnect test; see Current quarter).
- Robotics, cobot arms under the Universal Robots brand (over 110,000 sold since 2008) and autonomous mobile robots under the Mobile Industrial Robots (MiR) brand (over 11,000 sold). Robotics is sold mainly through distributors and OEMs and is built mainly in Denmark and the U.S.; most of its revenue is in foreign currencies, so a stronger dollar reduces it.
Demand is concentrated. The five largest direct customers were 44% of 2025 revenue (36% in 2024, 32% in 2023). Teradyne distinguishes a "specifying" customer that chooses the platform from the "purchasing" customer that places the order: in 2025 two specifying customers drove 12% and 10% of revenue, and a third, direct customer of Semiconductor Test accounted for 19%. At year-end 2025 two customers, primarily of Semiconductor Test, held about 22% and 20% of accounts receivable.
Test-business manufacturing is largely outsourced to contract manufacturers in Malaysia and Thailand (Flex, Plexus and SAM Meerkat), alongside the company's own internal manufacturing of FLEX products at its Cebu site. Principal competitors are Advantest, SPEA and Cohu in Semiconductor Test; Keysight, Test Research, Rohde & Schwarz, Anritsu and National Instruments in Product Test; and KUKA, ABB, FANUC, Yaskawa, Techman, Doosan, Omron and others in Robotics. Teradyne had about 6,600 employees at December 31, 2025, about 2,200 of them in the United States.
Strategy, as the company states it, is to grow revenue and share with differentiated products in expanding markets, and to balance capital between organic and inorganic growth and returns to shareholders through buybacks and dividends. It owns a 10% equity stake in Technoprobe S.p.A., bought in May 2024 for 483.1 million Euros ($524.1 million) and accounted for under the equity method with a board seat; the 10-Q puts the stake's market value at $2,242.4 million at September 27, 2026 against a carrying value of $518.6 million.
Risk factors
From the FY2025 10-K, accession 0001193125-26-059002 (Item 1A). The Q3 2026 10-Q, accession 0001193125-26-441091, states that these risk factors remain applicable and adds none.
- Cyclicality. Revenue depends on the capital spending of semiconductor, electronics and industrial manufacturers, which has historically swung with sudden economic slowdowns and recurring industry over-supply. Downturns bring price competition, excess and obsolete inventory, receivable risk and restructuring charges, and the company says it cannot ensure that a quarter's revenue or orders will be sustained.
- Customer concentration and consolidation. With the top five direct customers at 44% of 2025 revenue and three customers each tied to 10% or more, losing or seeing a large order cut from any one of them could materially reduce revenue; the company has limited contractual recourse if a major customer stops buying. Consolidation among chipmakers could deepen that dependence and pressure prices.
- Export controls and China. U.S. Entity List designations, the Foreign Direct Product Rule and the military end-user rule have restricted sales to certain Chinese customers, and the company expects more export-control rules. China has responded with blocking legislation whose effect is uncertain. Teradyne says it cannot quantify the sales impact but that compliance has limited its ability to compete in certain regions, where some competitors face no equivalent restrictions.
- Tariffs. U.S. tariffs and Chinese retaliatory tariffs could disrupt operations, supply chain and sales. The company says recent tariff changes have not had a material adverse effect to date.
- Competition and technology change. Competitors, emerging Asian suppliers and customers' in-house test development may match or beat Teradyne's products; failing to develop or win acceptance for new platforms would cut revenue. Multi-site (parallel) testing could also shrink the overall market for test equipment.
- Outsourced manufacturing and suppliers. Dependence on Flex, Plexus and SAM Meerkat in Malaysia and Thailand, and on some sole-source components, means a disruption could stop shipments of key products. The company notes suppliers may struggle to keep pace in a period of rapid growth, and that extended or non-cancellable purchase commitments create inventory risk if forecasts prove wrong.
- Acquisitions and joint ventures. Universal Robots, MiR, AET, Quantifi, the Technoprobe stake and later deals may not deliver expected benefits and could lead to goodwill or intangible-asset impairments.
- Tax. The effective rate depends on the geographic mix of earnings and on incentives such as the Singapore tax holiday, which saved $21.6 million ($0.14 per diluted share) in 2025 and was extended in December 2025 to December 31, 2035. Changes in tax law, including Pillar Two, or losing qualification could raise the rate.
- Debt and covenants. The secured revolving credit facility restricts liens, asset sales, investments and other actions and carries financial covenants; a breach could accelerate repayment.
- Currency. Most Robotics revenue is in foreign currencies while debt, buybacks and many liabilities are paid in dollars.
- Cybersecurity and AI. The company has experienced several attempted cyber-attacks on its network, none of which disrupted operations; a successful breach of its systems or products could cause losses and reputational harm. Its own use of AI tools carries competitive, intellectual-property, data-privacy and regulatory risks.
- Intellectual property, product liability and environment. Infringement claims could force licensing or product changes; product defects have led to recalls in the past; and the company is conducting groundwater and subsurface remediation at former manufacturing sites in Massachusetts and New Hampshire.
- Stock-price volatility and shareholder activism. Analyst rating changes or a failure to achieve guidance can move the stock sharply, and activist campaigns could disrupt plans.
Management's discussion, fiscal year 2025
From the FY2025 10-K, accession 0001193125-26-059002 (Item 7).
Revenue rose $370.1 million, or 13.1%, to $3,190.0 million in 2025. The growth was all in test: Semiconductor Test rose $399.8 million (18.8%) to $2,523.7 million, driven by AI-related compute demand in networking and from vertically integrated producers, and by system-level testers. Management said AI-related demand made up the majority of revenue in the second half of 2025. Memory test revenue held steady in a smaller market, helped by share gains in HBM and DRAM final test. Product Test grew $26.9 million (8.1%) to $358.0 million on defense and aerospace systems. Robotics fell $56.5 million (15.5%) to $308.3 million on lower sales of both cobots and mobile robots, although the fourth quarter was its third straight quarter of sequential growth.
Gross margin slipped to 58.2% from 58.5% on product mix. The service margin rose to 62.9% from 60.0%, which the company attributes mainly to the May 27, 2024 sale of its DIS business. Inventory provisions were $25.8 million, against $18.9 million in 2024. Selling and administrative expense rose $31.8 million to $648.9 million and engineering and development rose $43.7 million to $504.6 million, both because of higher Semiconductor Test spending partly offset by Robotics cuts. Restructuring included $29.4 million of severance, of which $24.3 million was for a Robotics restructuring affecting about 400 employees.
Pre-tax income by segment shows where the money was made. Semiconductor Test earned $700.7 million (up from $558.2 million), Product Test $60.7 million (down from $65.7 million) and Robotics lost $99.4 million (a wider loss than 2024's $77.6 million). Corporate and eliminations swung to a loss of $8.8 million from income of $62.7 million, mainly because 2024 included the gain on the DIS sale. The effective tax rate rose to 12.1% from 9.8% as benefits from uncertain-tax-position reserves and tax credits shrank. Net income was $554.0 million, or $3.47 per diluted share, against $542.4 million, or $3.32, in 2024.
Operating cash flow was $674.4 million (2024: $672.2 million), absorbing a $305.6 million increase in receivables. Capital expenditure was $224.0 million and acquisitions (Quantifi, and Infineon's automated test equipment team in Regensburg, Germany, bought January 31, 2025 for 17.6 million Euros, or $18.3 million) used $144.4 million. Teradyne returned $778.4 million to shareholders: $702.1 million of buybacks (6.3 million shares at an average $112.21) and $76.3 million of dividends. It borrowed a combined $250.0 million on its $750.0 million revolver to fund this, and $200.0 million was still outstanding at year-end. Cash, cash equivalents and marketable securities fell $275.5 million to $448.3 million. Purchase obligations were about $1,473.0 million, of which $1,415.1 million was due within twelve months.
Current quarter, third quarter 2026 (ended September 27, 2026)
From the Q3 2026 10-Q, accession 0001193125-26-441091, and the Q3 2026 earnings release, accession 0001193125-26-434981.
AI demand continued to drive revenue. Third-quarter revenue was $1,306.0 million, up 70% from $769.2 million a year earlier, though slightly below the second quarter's $1,329.0 million. Net income attributable to Teradyne was $342.4 million, or $2.17 per diluted share, against $119.6 million, or $0.75. On the company's non-GAAP basis, EPS was $2.29 against $0.85. The company said results exceeded the high end of its guidance.
- Semiconductor Test revenue rose $466.1 million (76.9%) to $1,072.0 million, its third straight quarter above $1.0 billion, on memory and AI-related compute. Memory revenue reached a record $301 million, the fourth consecutive quarter above $200 million. Segment pre-tax income rose to $366.9 million from $150.8 million.
- Product Test revenue rose $49.8 million (56.4%) to $138.1 million. The company attributes the increase to AI-related demand across board test, optical and high-speed interconnect, growth in wireless and defense/aerospace, and the addition of the MultiLane Test Products joint venture. Pre-tax income rose to $41.4 million from $15.9 million.
- Robotics revenue rose $20.7 million (27.6%) to $95.8 million, its highest third quarter ever, and the segment turned a small profit of $0.3 million against a $17.6 million loss a year earlier. The company credits higher volume, better mix and lower operating costs after its restructuring. Electronics and semiconductor customers were Robotics' largest end-market in the quarter.
Gross margin improved to 59.1% from 58.4% on higher sales and mix. Operating expenses grew more slowly than revenue: selling and administrative rose $29.9 million to $199.0 million (15.2% of revenue, from 22.0%) and engineering and development rose $38.3 million to $163.1 million (12.5%, from 16.2%). The company attributes both increases to strategic investment in Semiconductor Test and higher variable compensation. The effective tax rate was 14.8% (15.8% a year earlier). Revenue by customer location shifted: Korea rose to 32% of quarterly revenue from 12%, China was 21% and Taiwan fell to 14% from 37%.
For the nine months, revenue rose 86% to $3,917.4 million from $2,106.7 million, with Semiconductor Test up 101.5% to $3,304.6 million. Net income attributable to Teradyne was $1,115.8 million, or $7.08 per diluted share, against $296.8 million, or $1.85. Operating cash flow was $1,047.9 million, after the company invested in working capital, receivables, prepayments and inventories rose $302.7 million, $224.9 million and $178.8 million respectively. Capital expenditure was $241.8 million. Purchase commitments stood at about $2,252.9 million at quarter-end, of which $1,906.4 million is due within a year, up from $1,473.0 million at the end of 2025.
MultiLane Test Products. On April 8, 2026 Teradyne and HTP Holding SAL ("MultiLane") formed MultiLane Test Products Holding LLC (MLTP). MultiLane contributed its test and measurement business, and Teradyne took a controlling 75% interest for a purchase price of $157.8 million, subject to post-closing adjustments. MLTP makes test solutions for high-speed data connections in AI data-center equipment and is reported in Product Test. Preliminary allocation assigned $131.6 million to goodwill and $46.7 million to intangible assets, and valued the 25% minority interest at $35.8 million. Teradyne and the minority holder have call and put rights over the remaining 25% after a lock-up, with the earliest redemption in 2029 at a formula price.
Capital and liquidity. On August 7, 2026 Teradyne replaced its $750.0 million revolver, which was due to expire in December 2026, with a five-year $1.0 billion senior secured revolving credit facility maturing August 2031. The $200.0 million drawn at year-end was repaid, and nothing was outstanding at September 27, 2026. Cash, cash equivalents and marketable securities rose $176.6 million in the nine months to $624.9 million. Over the nine months the company paid $165.6 million, net of cash acquired, for acquisitions, mainly MLTP, and returned $234.5 million to shareholders: $173.5 million of buybacks (0.5 million shares at an average $349.62) and $61.0 million of dividends at $0.13 per share per quarter, up from $0.12. About $517.9 million of the $2.0 billion January 2023 buyback authorization remained at quarter-end.
Tariffs. Teradyne paid tariffs imposed under the International Emergency Economic Powers Act from their inception in 2025. U.S. Customs and Border Protection began accepting refund claims on April 20, 2026, and the company received refunds in the third quarter that it describes as immaterial.
Outlook. The company guided fourth-quarter 2026 revenue to $1,250 million–$1,350 million, with GAAP EPS of $1.88–$2.18 and non-GAAP EPS of $1.95–$2.25. Management says it plans to keep reinvesting, particularly in research and development, to support growth in 2027.
Subsequent events
From the subsequent-events note (Note V) and MD&A of the Q3 2026 10-Q, accession 0001193125-26-441091.
- FormFactor investment and collaboration (October 6, 2026). Teradyne signed a securities purchase agreement to make a $300.0 million minority, non-controlling equity investment in FormFactor, Inc., a provider of semiconductor test and measurement technologies. It also signed a collaboration agreement under which the two will develop joint solutions combining Teradyne's test platforms with FormFactor's probe, contactor and interface technologies, aimed at silicon photonics, high-performance compute, advanced packaging and high-bandwidth memory. The investment is expected to close within the fourth quarter of 2026, subject to customary closing conditions and regulatory approvals. The 10-Q does not disclose the size of the stake as a percentage of FormFactor's shares.
The note lists no other post-period acquisitions, divestitures, borrowings or litigation outcomes.
AI synthesis of events in nine filings
Filings that contain financial statements
Each Teradyne earnings release (Exhibit 99.1 to a Form 8-K, Item 2.02) carries condensed consolidated statements of operations, balance sheets, and statements of cash flows, plus a GAAP to non-GAAP reconciliation.
- Form 8-K filed 2026-10-28, accession 0001193125-26-434981: third quarter ended September 27, 2026, with nine-month figures. Statements of operations, balance sheet (September 27, 2026 vs. December 31, 2025), and cash flows.
- Form 8-K filed 2026-07-29, accession 0001193125-26-321933: second quarter ended June 28, 2026, with six-month figures. Statements of operations, balance sheet, and cash flows.
- Form 8-K filed 2026-04-29, accession 0001193125-26-188706: first quarter ended March 29, 2026. Statements of operations, balance sheet, and cash flows.
- Form 8-K filed 2026-02-03, accession 0001193125-26-034348: fourth quarter and full year ended December 31, 2025. Statements of operations, balance sheet, and cash flows.
Earnings and guidance
October 27, 2026 (third quarter 2026 results; 8-K 0001193125-26-434981). Revenue was $1,306 million, up 70% from $769 million a year earlier and down from $1,329 million in the second quarter. By group: Semiconductor Test $1,072 million, Product Test $138 million, Robotics $96 million. GAAP net income attributable to Teradyne was $342.4 million, or $2.17 per diluted share (year-ago $0.75); non-GAAP was $2.29 per diluted share (year-ago $0.85). The company said revenue exceeded the high end of its guidance, with record revenue in Memory and Integrated Systems Test, and that Robotics achieved profitability. Fourth quarter guidance: revenue of $1,250 million to $1,350 million, GAAP earnings of $1.88 to $2.18 per diluted share, and non-GAAP earnings of $1.95 to $2.25 per diluted share. That revenue range brackets the third quarter result and is roughly flat at the midpoint.
Nine-month items shown in the release: net revenues of $3,917 million (year-ago $2,107 million); operating cash flow of $1,048 million; share repurchases of $173.5 million and dividends paid of $61.0 million; acquisitions of businesses, net of cash acquired, of $165.6 million. The balance sheet shows no short-term debt at September 27, 2026 (versus $200 million at December 31, 2025), after $350 million of revolver borrowings and $550 million of repayments during the nine months. The quarterly dividend declared was $0.13 per share (year-ago $0.12).
July 28, 2026 (second quarter 2026 results; 8-K 0001193125-26-321933). Revenue was a record $1,329 million (year-ago $652 million, up 104%; first quarter 2026 $1,282 million), GAAP earnings $2.38 per diluted share and non-GAAP $2.47. The release cited record Memory revenue. Third quarter guidance of $1,200 million to $1,300 million of revenue was exceeded by the result reported in October.
April 28, 2026 (first quarter 2026 results; 8-K 0001193125-26-188706). Revenue was a record $1,282 million (year-ago $686 million, up 87%), GAAP earnings $2.53 per diluted share and non-GAAP $2.56. Management said approximately 70% of revenue was tied to AI-related demand. Second quarter guidance was revenue of $1,150 million to $1,250 million; the second quarter result of $1,329 million came in above it.
February 2, 2026 (fourth quarter and full year 2025 results; 8-K 0001193125-26-034348). Fourth quarter revenue was $1,083 million (up 44% from the fourth quarter of 2024), GAAP earnings $1.63 per diluted share and non-GAAP $1.80. Full-year 2025 revenue was $3,190 million, up 13%, with GAAP earnings of $3.47 and non-GAAP earnings of $3.96 per diluted share. First quarter 2026 guidance was revenue of $1,150 million to $1,250 million; the actual first quarter revenue of $1,282 million exceeded it.
Acquisitions and investments
MultiLane joint venture (closed April 8, 2026). Described in the quarterly report on Form 10-Q for the period ended September 27, 2026 (accession 0001193125-26-441091), Note D. Teradyne and HTP Holding SAL ("MultiLane") formed MultiLane Test Products Holding LLC ("MLTP"), in which Teradyne holds a controlling 75% interest and the remaining 25% is a redeemable noncontrolling interest. Total purchase price was $157.8 million, subject to post-closing adjustments, with goodwill of $131.6 million and acquired intangibles of $46.7 million. The 10-Q states Teradyne's right to buy, and the minority holder's right to sell, the remaining 25% begins no earlier than 2029. No Form 8-K in the period covers this transaction; it appears in the earnings releases only through cash-flow and balance-sheet line items and in the 10-Q.
FormFactor investment (signed October 6, 2026, not closed). The same 10-Q (Note V, Subsequent Events) states that on October 6, 2026 Teradyne entered into a securities purchase agreement and a collaboration agreement with FormFactor, Inc. Teradyne agreed to make a $300.0 million minority, non-controlling equity investment, expected to close within the fourth quarter of 2026 subject to customary closing conditions and regulatory approvals. No Form 8-K covers this agreement, and no filing reviewed states that it has closed.
Financing and capital actions
August 7, 2026: new $1.0 billion revolving credit facility (Form 8-K filed 2026-08-10, accession 0001193125-26-342367; Items 1.01 and 2.03). Five-year senior secured revolver with PNC Bank, National Association as administrative agent, no borrowings at signing. Interest is SOFR plus 1.00% to 1.75% (1.00% to 1.50% during an investment-grade suspension period). Covenants: maximum consolidated leverage ratio of 3.50 to 1.00 (4.00 to 1.00 for the quarter of, and three quarters after, an acquisition above $200 million) and, outside an investment-grade period, a minimum interest coverage ratio of 2.50 to 1.00. Collateral and guarantees are released if Teradyne earns investment-grade ratings from at least two of S&P, Moody's, and Fitch. The 10-Q states it replaced a $750.0 million facility from May 2020 that was terminated early and had been due to expire in December 2026, and that nothing was outstanding at September 27, 2026.
Share repurchases. The 10-Q reports 0.5 million shares repurchased for $173.5 million (average $349.62 per share) in the nine months ended September 27, 2026, against a $2.0 billion program approved in January 2023, under which cumulative repurchases are $1,481.8 million. In the prior-year nine months the company repurchased 5.1 million shares for $523.5 million.
Management and governance
- October 28, 2025 (8-K 0001193125-25-253857, Item 5.02): Michelle Turner succeeded Sanjay Mehta as Vice President, Chief Financial Officer and Treasurer effective November 3, 2025; Mr. Mehta stayed on as an executive advisor. She signed the October 2026 earnings 8-K as CFO.
- May 8, 2026 annual meeting (8-K filed 2026-05-11, accession 0001193125-26-215848, Item 5.07): shareholders elected nine directors (including Drew Henry and Necip Sayiner, who joined the board July 1, 2025), approved executive compensation on an advisory basis, and ratified PricewaterhouseCoopers LLP for fiscal 2026.
- September 2, 2025 (8-K 0001193125-25-194047, Item 5.02): the tenure of Ujjwal Kumar as President of Teradyne Robotics ended August 29, 2025; he remained employed through September 30, 2025 under a separation agreement.
Not reflected in the 8-K filings
The MultiLane joint venture (closed April 2026) and the FormFactor agreement (October 2026) were not the subject of any Form 8-K in the period; both are disclosed in the quarterly report on Form 10-Q (accession 0001193125-26-441091).
Financials
Figures link to the filing they came from. Wherever the SEC filing tags a number, that number is linked: click it and the filing opens at the exact line that prints it. A figure with no link was either derived by AI, such as a margin, free cash flow or a trailing-twelve-month total, or taken from a filing that does not tag its numbers, such as an earnings release.
About this file
| Ticker | TER |
|---|---|
| CIK | 0000097210 |
| Company | Teradyne, Inc. |
| Business type | industrial |
| Schema template | standard (technology hardware): revenue split into products and services, cost of revenues, gross profit, operating expenses, income from operations, net income attributable to Teradyne, EPS; balance sheet liquidity, debt and equity; operating cash flow, capital expenditures and free cash flow; revenue and pre-tax income for the three reportable segments |
| Reporting currency | USD |
| Converted to USD | no |
| Units | actual US dollars (not thousands); share counts in actual shares; per-share figures in dollars |
TER annual income statement, balance sheet and cash flow
Taken from the SEC filings and normalized to actual dollars.
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Period start | 2025-01-01 | 2024-01-01 | 2023-01-01 |
| Period end | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Period type | fiscal year | fiscal year | fiscal year |
| Source accession | 10-K | 10-K | 10-K |
| Income statement | |||
| Product revenue | 2,660,190,000 | 2,294,935,000 | 2,096,286,000 |
| Service revenue | 529,834,000 | 524,945,000 | 580,012,000 |
| Total revenues | 3,190,024,000 | 2,819,880,000 | 2,676,298,000 |
| Cost of products | 1,136,026,000 | 960,888,000 | 882,892,000 |
| Cost of services | 196,653,000 | 210,065,000 | 256,658,000 |
| Total cost of revenues | 1,332,679,000 | 1,170,953,000 | 1,139,550,000 |
| Gross profit | 1,857,345,000 | 1,648,927,000 | 1,536,748,000 |
| Selling and administrative | 648,874,000 | 617,047,000 | 577,315,000 |
| Engineering and development | 504,596,000 | 460,876,000 | 418,089,000 |
| Acquired intangible assets amortization | 15,270,000 | 18,764,000 | 18,999,000 |
| Restructuring and other | 38,554,000 | 15,571,000 | 21,277,000 |
| Total operating expenses | 1,207,294,000 | 1,055,139,000 | 1,035,680,000 |
| Income from operations | 650,051,000 | 593,788,000 | 501,068,000 |
| Income before income taxes | 653,260,000 | 609,086,000 | 525,572,000 |
| Income tax provision | 79,299,000 | 59,503,000 | 76,820,000 |
| Consolidated net income | 554,047,000 | 542,372,000 | 448,752,000 |
| Net income attributable to teradyne | 554,047,000 | 542,372,000 | 448,752,000 |
| Basic EPS | 3.48 | 3.41 | 2.91 |
| Diluted EPS | 3.47 | 3.32 | 2.73 |
| Basic shares | 159,119,000 | 159,083,000 | 154,310,000 |
| Diluted shares | 159,719,000 | 163,314,000 | 164,304,000 |
| Equity in net earnings of affiliate | -19,914,000 | -7,211,000 | 0 |
| Balance sheet | |||
| Cash and cash equivalents | 293,751,000 | 553,354,000 | |
| Marketable securities current | 28,247,000 | 46,312,000 | |
| Accounts receivable net | 786,913,000 | 471,426,000 | |
| Inventories net | 379,552,000 | 298,492,000 | |
| Prepayments | 427,564,000 | 429,086,000 | |
| Total current assets | 1,949,300,000 | 1,816,397,000 | |
| Property plant and equipment net | 562,999,000 | 508,171,000 | |
| Marketable securities long term | 126,256,000 | 124,121,000 | |
| Equity method investment | 537,098,000 | 494,494,000 | |
| Acquired intangible assets net | 51,271,000 | 15,927,000 | |
| Goodwill | 521,019,000 | 395,367,000 | |
| Total assets | 4,183,599,000 | 3,708,714,000 | |
| Accounts payable | 269,185,000 | 134,792,000 | |
| Deferred revenue and customer advances | 153,124,000 | 107,710,000 | |
| Short term debt | 200,000,000 | 0 | |
| Total current liabilities | 1,115,207,000 | 624,579,000 | |
| Total liabilities | 1,387,847,000 | 889,420,000 | |
| Retained earnings | 744,435,000 | 970,761,000 | |
| Total shareholders equity | 2,795,752,000 | 2,819,294,000 | |
| Total liabilities and shareholders equity | 4,183,599,000 | 3,708,714,000 | |
| Common shares outstanding | 156,088,000 | 161,722,000 | |
| Total debt | 200,000,000 | 0 | |
| Cash flow | |||
| Depreciation | 111,445,000 | 100,977,000 | 92,118,000 |
| Stock based compensation | 63,999,000 | 60,122,000 | 57,682,000 |
| Amortization | 16,536,000 | 18,764,000 | 18,768,000 |
| Operating cash flow | 674,415,000 | 672,176,000 | 585,231,000 |
| Proceeds from revolving credit facility | 250,000,000 | 185,000,000 | 0 |
| Cash and cash equivalents end of period | 293,751,000 | 553,354,000 | 757,571,000 |
| Capital expenditures | -224,009,000 | -198,095,000 | -159,642,000 |
| Acquisitions of businesses net of cash acquired | -144,380,000 | 0 | 0 |
| Purchase of investment in a business | -25,519,000 | -532,060,000 | 0 |
| Net cash used for investing activities | -368,617,000 | -622,342,000 | -179,645,000 |
| Repayments of revolving credit facility | -50,000,000 | -185,000,000 | 0 |
| Dividends paid | -76,313,000 | -76,423,000 | -67,878,000 |
| Repurchase of common stock | -702,095,000 | -198,574,000 | -397,241,000 |
| Net cash used for financing activities | -562,250,000 | -251,767,000 | -501,912,000 |
| Net change in cash and cash equivalents | -259,603,000 | -204,217,000 | -97,202,000 |
| Free cash flow | 450,406,000 | 474,081,000 | 425,589,000 |
| Shareholder returns | |||
| Dividends declared per share | 0.48 | 0.48 | 0.44 |
| Segments | |||
| Semiconductor test | |||
| Revenue | 2,523,744,000 | 2,123,920,000 | 1,957,188,000 |
| Income before taxes | 700,734,000 | 558,168,000 | 498,504,000 |
| Robotics | |||
| Revenue | 308,295,000 | 364,848,000 | 375,183,000 |
| Income before taxes | -99,367,000 | -77,552,000 | -54,252,000 |
| Product test | |||
| Revenue | 357,985,000 | 331,112,000 | 343,927,000 |
| Income before taxes | 60,692,000 | 65,724,000 | 79,457,000 |
| Corporate and eliminations | |||
| Income before taxes | -8,799,000 | 62,746,000 | 1,863,000 |
TER quarterly income statement, balance sheet and cash flow
Taken from the SEC filings and normalized to actual dollars.
| Q3 FY2026 | Q3 FY2025 | |
|---|---|---|
| Fiscal quarter | 3 | 3 |
| Period start | 2026-06-29 | 2025-06-30 |
| Period end | 2026-09-27 | 2025-09-28 |
| Period type | three months | three months |
| Source accession | 10-Q | 10-Q |
| Cash flow source accession | 0001193125-26-434981 | 0001193125-26-434981 |
| Income statement | ||
| Product revenue | 1,164,165,000 | 632,104,000 |
| Service revenue | 141,785,000 | 137,106,000 |
| Total revenues | 1,305,950,000 | 769,210,000 |
| Cost of products | 485,092,000 | 270,634,000 |
| Cost of services | 49,582,000 | 49,270,000 |
| Total cost of revenues | 534,674,000 | 319,904,000 |
| Gross profit | 771,276,000 | 449,306,000 |
| Selling and administrative | 198,968,000 | 169,144,000 |
| Engineering and development | 163,092,000 | 124,760,000 |
| Acquired intangible assets amortization | 5,251,000 | 3,514,000 |
| Restructuring and other | 1,997,000 | 6,585,000 |
| Total operating expenses | 369,308,000 | 304,003,000 |
| Income from operations | 401,968,000 | 145,303,000 |
| Income before income taxes | 404,291,000 | 148,100,000 |
| Income tax provision | 59,833,000 | 23,344,000 |
| Equity in net earnings of affiliate | 3,281,000 | -5,198,000 |
| Consolidated net income | 347,739,000 | 119,558,000 |
| Net income attributable to noncontrolling interests | 5,332,000 | 0 |
| Net income attributable to teradyne | 342,407,000 | 119,558,000 |
| Basic shares | 156,262,000 | 158,595,000 |
| Diluted shares | 157,502,000 | 159,097,000 |
| Basic EPS | 2.19 | 0.75 |
| Diluted EPS | 2.17 | 0.75 |
| Balance sheet | ||
| Cash and cash equivalents | 460,742,000 | |
| Marketable securities current | 5,847,000 | |
| Accounts receivable net | 1,110,798,000 | |
| Inventories net | 574,992,000 | |
| Prepayments | 613,658,000 | |
| Total current assets | 2,790,222,000 | |
| Property plant and equipment net | 679,603,000 | |
| Marketable securities long term | 158,276,000 | |
| Equity method investment | 518,559,000 | |
| Acquired intangible assets net | 96,662,000 | |
| Goodwill | 663,776,000 | |
| Total assets | 5,449,193,000 | |
| Accounts payable | 516,967,000 | |
| Deferred revenue and customer advances | 211,683,000 | |
| Short term debt | 0 | |
| Total current liabilities | 1,341,436,000 | |
| Total liabilities | 1,712,232,000 | |
| Redeemable noncontrolling interests | 49,065,000 | |
| Retained earnings | 1,618,902,000 | |
| Total shareholders equity | 3,687,896,000 | |
| Total liabilities redeemable noncontrolling interests and equity | 5,449,193,000 | |
| Common shares outstanding | 156,150,000 | |
| Total debt | 0 | |
| Cash flow | ||
| Depreciation | 31,372,000 | 26,649,000 |
| Stock based compensation | 21,684,000 | 15,531,000 |
| Amortization | 5,504,000 | 3,867,000 |
| Operating cash flow | 313,614,000 | 49,051,000 |
| Acquisitions of businesses net of cash acquired | 0 | 0 |
| Proceeds from revolving credit facility | 0 | 200,000,000 |
| Repayments of revolving credit facility | 0 | 0 |
| Net change in cash and cash equivalents | 111,204,000 | -66,552,000 |
| Cash and cash equivalents end of period | 460,742,000 | 272,700,000 |
| Capital expenditures | -86,324,000 | -46,692,000 |
| Purchase of investment in a business | -10,870,000 | -20,151,000 |
| Net cash used for investing activities | -97,159,000 | -67,456,000 |
| Dividends paid | -20,314,000 | -18,990,000 |
| Repurchase of common stock | -99,264,000 | -243,785,000 |
| Net cash used for financing activities | -104,697,000 | -47,791,000 |
| Free cash flow | 227,290,000 | 2,359,000 |
| Shareholder returns | ||
| Dividends declared per share | 0.13 | 0.12 |
| Segments | ||
| Semiconductor test | ||
| Revenue | 1,072,011,000 | 605,867,000 |
| Income before taxes | 366,915,000 | 150,832,000 |
| Robotics | ||
| Revenue | 95,828,000 | 75,087,000 |
| Income before taxes | 345,000 | -17,567,000 |
| Product test | ||
| Revenue | 138,111,000 | 88,256,000 |
| Income before taxes | 41,422,000 | 15,896,000 |
| Corporate and eliminations | ||
| Income before taxes | -4,391,000 | -1,061,000 |
TER year-to-date income statement and cash flow
Taken from the SEC filings and normalized to actual dollars.
| Nine months ended September 27, 2026 | Nine months ended September 28, 2025 | |
|---|---|---|
| Period start | 2026-01-01 | 2025-01-01 |
| Period end | 2026-09-27 | 2025-09-28 |
| Period type | nine months | nine months |
| Source accession | 10-Q | 10-Q |
| Income statement | ||
| Product revenue | 3,498,463,000 | 1,716,718,000 |
| Service revenue | 418,971,000 | 389,969,000 |
| Total revenues | 3,917,434,000 | 2,106,687,000 |
| Cost of products | 1,425,757,000 | 727,198,000 |
| Cost of services | 144,831,000 | 141,834,000 |
| Total cost of revenues | 1,570,588,000 | 869,032,000 |
| Gross profit | 2,346,846,000 | 1,237,655,000 |
| Selling and administrative | 558,224,000 | 484,182,000 |
| Engineering and development | 454,938,000 | 361,331,000 |
| Acquired intangible assets amortization | 12,447,000 | 11,820,000 |
| Restructuring and other | 8,455,000 | 23,472,000 |
| Total operating expenses | 1,034,064,000 | 880,805,000 |
| Income from operations | 1,312,782,000 | 356,850,000 |
| Income before income taxes | 1,313,588,000 | 363,684,000 |
| Income tax provision | 188,778,000 | 50,148,000 |
| Consolidated net income | 1,121,533,000 | 296,827,000 |
| Net income attributable to noncontrolling interests | 5,684,000 | 0 |
| Net income attributable to teradyne | 1,115,849,000 | 296,827,000 |
| Basic shares | 156,381,000 | 160,021,000 |
| Diluted shares | 157,610,000 | 160,409,000 |
| Basic EPS | 7.14 | 1.85 |
| Diluted EPS | 7.08 | 1.85 |
| Equity in net earnings of affiliate | -3,277,000 | -16,709,000 |
| Cash flow | ||
| Depreciation | 90,256,000 | 79,484,000 |
| Stock based compensation | 63,649,000 | 47,561,000 |
| Amortization | 12,925,000 | 12,723,000 |
| Operating cash flow | 1,047,875,000 | 392,776,000 |
| Proceeds from revolving credit facility | 350,000,000 | 200,000,000 |
| Net change in cash and cash equivalents | 166,991,000 | -280,654,000 |
| Cash and cash equivalents end of period | 460,742,000 | 272,700,000 |
| Capital expenditures | -241,762,000 | -161,121,000 |
| Acquisitions of businesses net of cash acquired | -165,611,000 | -144,380,000 |
| Purchase of investment in a business | -20,900,000 | -25,519,000 |
| Net cash used for investing activities | -435,790,000 | -307,692,000 |
| Repayments of revolving credit facility | -550,000,000 | 0 |
| Dividends paid | -61,024,000 | -57,574,000 |
| Repurchase of common stock | -173,502,000 | -518,658,000 |
| Net cash used for financing activities | -445,657,000 | -361,410,000 |
| Free cash flow | 806,113,000 | 231,655,000 |
| Shareholder returns | ||
| Dividends declared per share | 0.39 | 0.36 |
| Segments | ||
| Semiconductor test | ||
| Revenue | 3,304,637,000 | 1,640,249,000 |
| Income before taxes | 1,262,288,000 | 402,397,000 |
| Robotics | ||
| Revenue | 287,003,000 | 218,940,000 |
| Income before taxes | -3,195,000 | -73,277,000 |
| Product test | ||
| Revenue | 325,794,000 | 247,498,000 |
| Income before taxes | 64,118,000 | 40,084,000 |
| Corporate and eliminations | ||
| Income before taxes | -9,623,000 | -5,520,000 |
TER trailing twelve month income statement and cash flow
Derived by AI from the figures the filings report. No filing prints these, so none of them is linked.
| Twelve months ended September 27, 2026 | |
|---|---|
| Period start | 2025-09-29 |
| Period end | 2026-09-27 |
| Period type | trailing twelve months |
| Source accession | 10-Q |
| Derived from accessions | 10-K, 10-Q |
| Income statement | |
| Total revenues | 5,000,771,000 |
| Total cost of revenues | 2,034,235,000 |
| Gross profit | 2,966,536,000 |
| Total operating expenses | 1,360,553,000 |
| Income from operations | 1,605,983,000 |
| Income before income taxes | 1,603,164,000 |
| Income tax provision | 217,929,000 |
| Consolidated net income | 1,378,753,000 |
| Net income attributable to teradyne | 1,373,069,000 |
| Cash flow | |
| Operating cash flow | 1,329,514,000 |
| Capital expenditures | -304,650,000 |
| Free cash flow | 1,024,864,000 |
Adjustments
| Splits applied | none |
|---|---|
| ADR ratio | n/a |
| FX | none; Teradyne reports in US dollars |
Notes
- Template: a standard technology-hardware layout. Teradyne sells automated test equipment and robots, so the record follows revenue (products and services), cost of revenues, gross profit, operating expenses, income from operations and net income, plus the balance sheet, operating cash flow, capital expenditures and free cash flow. It also carries revenue and pre-tax income for the three reportable segments: Semiconductor Test, Robotics and Product Test.
- Periods covered. The FY2025 10-K (accession 0001193125-26-059002) supplies the income statements and cash flows for FY2025, FY2024 and FY2023, and the balance sheets at December 31, 2025 and 2024. FY2023 has no balance sheet here because the 10-K does not print one for that year. The Q3 2026 10-Q (accession 0001193125-26-441091) supplies the three months ended September 27, 2026 and September 28, 2025, the nine-month periods ending on those dates, and the balance sheet at September 27, 2026. The 10-Q's December 31, 2025 balance sheet column agrees line for line with the 10-K.
- Fiscal calendar: the fiscal year ends December 31, and interim quarters end on a Sunday. Q3 FY2026 ran from June 29 to September 27, 2026, and Q3 FY2025 from June 30 to September 28, 2025.
- Three-month cash flows. The 10-Q prints its cash flow statement for the nine months only. The cash flow figures for Q3 FY2026 and Q3 FY2025 alone therefore come from the condensed consolidated statements of cash flows in Teradyne's third-quarter 2026 earnings release (Form 8-K, accession 0001193125-26-434981, Exhibit 99.1), and each quarter records that accession as cash_flow_source_accession. The release's nine-month columns agree with the 10-Q.
- Cash flow amounts keep the sign the statements print: outflows such as capital expenditures, acquisitions, share repurchases and dividend payments are negative.
- Free cash flow is calculated here as net cash provided by operating activities less purchases of property, plant and equipment. Teradyne does not report a free cash flow figure in these filings.
- Net income. On April 8, 2026 Teradyne formed MultiLane Test Products Holding LLC (MLTP), a joint venture in which it holds 75%; the remaining 25% is a redeemable noncontrolling interest. For the 2026 periods, consolidated_net_income is the statement's consolidated net income, and net_income_attributable_to_teradyne (the basis for EPS) is consolidated net income less the noncontrolling interests' share. The FY2023 to FY2025 statements had no noncontrolling interests and print a single net income line, which is recorded under both names.
- Balance sheet at September 27, 2026: redeemable noncontrolling interests of $49.1 million sit between liabilities and equity, and total_shareholders_equity is total Teradyne shareholders' equity. Total liabilities, redeemable noncontrolling interests and equity equal total assets of $5.45 billion.
- total_debt is the balance sheet's short-term debt, which is borrowings under the revolving credit facility and the only debt line Teradyne reports: $200.0 million at December 31, 2025, and none at December 31, 2024 or September 27, 2026. On August 7, 2026 Teradyne replaced its $750.0 million facility with a five-year, $1.0 billion senior secured revolving credit facility (10-Q, Note on debt).
- Equity in net earnings of affiliate keeps the sign printed in the statement of operations: a negative figure is Teradyne's share of the affiliate's loss and reduces net income. Q3 FY2026 shows a $3.3 million gain.
- Cost of revenues excludes amortization of acquired intangible assets, which the statements report separately within operating expenses, and gross profit is the figure the statements print. FY2024 operating expenses include a $57.1 million gain on the sale of a business, shown on the statement as a reduction of operating expenses; it is not broken out as a separate field.
- Segments. The segment measure is income (loss) before income taxes. Interest, foreign exchange, pension actuarial items and certain other charges sit in corporate_and_eliminations, so the three segments plus that line add up to consolidated pre-tax income. In the FY2025 10-K, FY2024 and FY2023 appear under the three-segment structure adopted in 2025; as of December 31, 2024 Teradyne had reported two segments, Semiconductor Test and Robotics.
- Per-share and share data: EPS is as printed. Weighted average shares and shares outstanding were printed in thousands and are stated here in actual shares. dividends_declared_per_share is the cash dividend per share printed in the statements of shareholders' equity. No stock split took place in these periods, and Teradyne reports in US dollars, so no split, currency or ADR adjustment applies.
- The trailing twelve months to September 27, 2026 are calculated as FY2025 plus the nine months ended September 27, 2026, less the nine months ended September 28, 2025.
- The September quarter's earnings release also prints a column for the quarter ended June 28, 2026. That quarter does not appear on the face of the FY2025 10-K or the Q3 2026 10-Q, so it is not included here; it is covered with Teradyne's Q2 2026 results.
Uncertainties
- The MLTP purchase price allocation is preliminary (10-Q, Note D): the $131.6 million of goodwill and $46.7 million of acquired intangible assets assigned to MLTP may be revised within the measurement period, up to twelve months from the April 8, 2026 acquisition date.
- The three-month cash flow figures for Q3 FY2026 and Q3 FY2025 come from the unaudited earnings release, not the 10-Q, which does not print a three-month cash flow statement.
Company details
| Name | Teradyne, Inc |
|---|---|
| Ticker | TER |
| CIK | 0000097210 |
| Exchange | Nasdaq |
| State | Massachusetts |
| Incorporation | Massachusetts |
| SIC | 3825 |
| Office | Industrial Applications and Services |
| Industry | Instruments For Meas & Testing of Electricity & Elec Signals |
Fiscal period
| Fiscal year | 2026 |
|---|---|
| Fiscal period | Q3 |
| Tag | FY26Q3 |
| Period end | 2026-09-27 |
| Form | 10-Q |
| Accession | 0001193125-26-441091 |
| Fiscal year end | 1231 |
| Source | facts |
Source filings
| Role | Current | Form | Fiscal year | Fiscal period | Tag | Period end | Filed | Accession | Source |
|---|---|---|---|---|---|---|---|---|---|
| annual | no | 10-K | 2025 | FY | FY25 | 2025-12-31 | 2026-02-19 | 0001193125-26-059002 | reported |
| quarterly | yes | 10-Q | 2026 | Q3 | FY26Q3 | 2026-09-27 | 2026-10-30 | 0001193125-26-441091 | facts |